Under construction – not a live service

Skip to content

Frontlight Research

Trial site

UMM Universitätsmedizin Mannheim

Mannheim, 68167, GermanyNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Metastatic breast cancer

Running trials

Active, not recruiting
A randomized, double-blind, Phase III Study of AZD9833 plus CDK4/6 inhibitor in patients with metastatic breast cancer with detectable ESR1 mutation
NCT04964934· Phase 3· AstraZeneca AB· Source

Site data: EU CTIS (euclinicaltrials.eu)Updated 5 Nov 2026

Report an error

Under construction, not live – UMM Universitätsmedizin Mannheim: trial site – Frontlight Research